ORAL SUBMUCOUS FIBROSIS

Clinical trials for ORAL SUBMUCOUS FIBROSIS explained in plain language.

Never miss a new study

Get alerted when new ORAL SUBMUCOUS FIBROSIS trials appear

Sign up with your email to follow new studies for ORAL SUBMUCOUS FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Common diabetes drug tested to fight mouth scarring

Disease control Completed

This study tested whether two existing drugs, metformin (a diabetes medication) and pirfenidone (an anti-scarring drug), could help treat oral submucous fibrosis—a chronic condition that causes scarring in the mouth and can limit mouth opening. Researchers first tested the drugs …

Matched conditions: ORAL SUBMUCOUS FIBROSIS

Phase: PHASE1, PHASE2 • Sponsor: Ziauddin University • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

ORAL SUBMUCOUS FIBROSIS

Get alerted when new ORAL SUBMUCOUS FIBROSIS trials appear

Common diabetes drug tested to fight mouth scarring